Glenn Krinsky advises academic medical centers and major nonprofit hospital systems in California, and across the United States, with respect to their regulatory, transactional, operational, and investigatory affairs.

Glenn has established himself as one of the nation's foremost practitioners in the representation of organ transplant programs. These representations include complex proceedings before the United Network for Organ Sharing (UNOS) and the Centers for Medicare and Medicaid Services (CMS). He also represents clients in the conduct of internal investigations.

Prior to joining Jones Day, Glenn served as chief legal officer and executive vice president of City of Hope National Medical Center and Beckman Research Institute in Duarte, California, one of the nation's most renowned biomedical research and clinical cancer treatment facilities. He was responsible for all health care law issues, as well as litigation, corporate governance, labor and employment, patent and trademark portfolio management, bond financings, nonprofit tax and other section 501(c)(3) issues, real estate transactions, crisis management, and federal lobbying activities. Glenn supervised City of Hope's 2002 trial against biotechnology industry leader Genentech, which resulted in a jury verdict in excess of $300 million in compensatory damages, a verdict upheld by both the California Court of Appeal and the California Supreme Court. He also successfully defended City of Hope in a comprehensive investigation conducted by the California Attorney General's Office, which resulted in a "no-action" letter, and successfully negotiated with major media organizations, including the CBS News program "60 Minutes" and the Los Angeles Times, regarding coverage of the issues presented in the attorney general's investigation.